Gene · 9965
Papers4,178
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,178
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell Technologies Provide Novel Insights into Liver Physiology and Pathology. | J Clin Transl Hepatol | 2024 | 38250462 | PubTator, text mining | PubMed |
| Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report. | Hered Cancer Clin Pract | 2024 | 38238849 | PubTator, text mining | PubMed |
| Obesity surgery and neural correlates of human eating behaviour: A systematic review of functional MRI studies. | Neuroimage Clin | 2024 | 38237270 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype. | Discov Oncol | 2024 | 38228856 | PubTator, text mining | PubMed |
| FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis. | EMBO Mol Med | 2024 | 38228803 | PubTator, text mining | PubMed |
| Predictive value of serum fibroblast growth factor 19 and liver stiffness for intestinal failure associated liver disease-cholestasis. | Clin Nutr ESPEN | 2024 | 38220411 | PubTator, text mining | PubMed |
| Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis. | Gut Microbes | 2024 | 38214604 | PubTator, text mining | PubMed |
| Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases. | J Intern Med | 2024 | 38212977 | PubTator, text mining | PubMed |
| What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside. | J Clin Med | 2024 | 38202285 | PubTator, text mining | PubMed |
| The gut-liver axis in hepatobiliary diseases. | Inflamm Regen | 2024 | 38191517 | PubTator, text mining | PubMed |
| EPYC functions as a novel prognostic biomarker for pancreatic cancer. | Sci Rep | 2024 | 38184732 | PubTator, text mining | PubMed |
| Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma. | Cell Death Dis | 2024 | 38182569 | PubTator, text mining | PubMed |
| Bile salt signaling and bile salt-based therapies in cardiometabolic disease. | Clin Sci (Lond) | 2024 | 38180064 | PubTator, text mining | PubMed |
| Circulating inflammatory biomarkers and risk of intracranial aneurysm: a Mendelian randomization study. | Eur J Med Res | 2024 | 38173028 | PubTator, text mining | PubMed |
| Genetic correction of induced pluripotent stem cells from a DFNA36 patient results in morphologic and functional recovery of derived hair cell-like cells. | Stem Cell Res Ther | 2024 | 38167128 | PubTator, text mining | PubMed |
| The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease. | Int J Biol Sci | 2024 | 38164174 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7. | Lab Invest | 2024 | 38154497 | PubTator, text mining | PubMed |
| Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis. | Redox Biol | 2024 | 38154380 | PubTator, text mining | PubMed |
| Lysine tRNA fragments and miR-194-5p co-regulate hepatic steatosis via β-Klotho and perilipin 2. | Mol Metab | 2024 | 38141848 | PubTator, text mining | PubMed |
| Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts. | Cell Mol Gastroenterol Hepatol | 2024 | 38109970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9965/papers?page=19